Impact of COX-2, IL-1β, TNF-α, IL-4 and IL-10 on the process of carcinogenesis in the large bowel

Polish Journal of Pathology

Volumn 63, Issue 4, 2012, Pages 221-227

  Marszałek, Andrzej ^a,b   Szylberg, Łukasz ^a   Wiśniewska, Ewa ^a   Marlena, Janiczek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Colorectal carcinogenesis; Inflammatory cytokines; Serrated pathway

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CELL TRANSFORMATION; COLON POLYP; COLORECTAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; PRECANCER;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; COLONIC POLYPS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYTOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-4; MIDDLE AGED; PRECANCEROUS CONDITIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873810224     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: 10.5114/PJP.2012.32768     Document Type: Article

References (20)

1. Shike M. Diet and lifestyle in the prevention of colorectal cancer: an overview. Am J Med 1999; 106: 11S-15S.
2. Stefanius K. Colorectal carcinogenesis via serrated route. Acta Univ Oul D 2011; 1091.
3. Asting AG, Carén H, Andersson M, et al. COX-2 gene expression in colon cancer tissue related to regulating factors and promotor methylation status. BMC Cancer 2011; 11: 238.
4. Balbinotti RA, Ribeiro U Jr, Sakai P, et al. hMLH1, hMSH2 and cyclooxygenase-2 (Cox-2) in sporadic colorectal polyps. Anticancer Res 2007; 27: 4465-4471.
5. Kawasaki T, Nosho K, Ohnishi M, et al. Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma. BMC Cancer 2008; 8: 33.
6. Smalley W, Ray WA, Daugherty J, Griffin MR. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 1999; 159: 161-166.
7. van Stolk R, Stoner G, Hayton WL, et al. Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin Cancer Res 2000; 6: 78-89.
8. Din FV, Theodoratou E, Farrington SM, et al. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 2010; 59:1670-1679.
9. Cacev T, Radosević S, Krizanac S, Kapitanović S. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 2008; 29: 1572-1580.
10. Stanilov N, Stankova N, Miteva L, et al. Role of IL-12P40 and IL-10 in progression of colorectal cancer. Trakia Journal of Sciences 2010; 8: 132-136.
11. Stanilov N, Miteva L, Deliysky T, et al. Advanced colorectal cancer is associated with enhanced IL-23 and IL-10 serum levels. Labmedicine 2010; 41: 159-163.
12. Maihöfner C, Charalambous MP, Bhambra U, et al. Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis 2003; 24: 665-671.
13. Shimizu S, Nishikawa Y, Kuroda K, et al. Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res 1996; 56: 3366-3370.
14. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003; 300: 1527-1528.
15. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-1964.
16. Kanai T, Watanabe M, Hayashi A, et al. Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion. Br J Cancer 2000; 82: 1717-1723.
17. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7: 211-217.
18. Linares L, Poiterin A, De la Penna C, et al. The prescription of oral anticancer drugs: Another perspective. Rep Pract Oncol Radiother 2012; 17: 295-297.
19. Rao VP, Poutahidis T, Ge Z, et al. Pro-inflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 2006; 66: 57-61.
20. Poutahidis T, Haigis KM, Rao VP, et al. Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma. Carcinogenesis 2007; 28: 2614-2623.